Cite
APA Citation
Halder, S., Khan, W., Wang, X., Kuhns, S., Sweet, H., Reinisch, W., & McBride, H. (n.d.). p071 Supporting extrapolation of indications for ABP 501, the first adalimumab biosimilar: focus on Crohn's disease. Journal of Crohn's and colitis, 13, S121. http://access.bl.uk/ark:/81055/vdc_100094064212.0x00000b